Monograph
V08AB05 - Iopromide |
Not porphyrinogenic |
NP |
Rationale
No significant biotransformation.
Chemical description
Watersoluble iodated X-ray contrast medium. Excreted in unchanged form.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Ultravist · Ultravist-240 mg/ml, oplossing voor injectie · Ultravist-300 mg/ml, oplossing voor injectie · Ultravist-370 mg/ml, oplossing voor injectieBelgium
Ultravist · Ultravist 240 240 mg/ml sol. inj./perf. i.v. flac. · Ultravist 300 300 mg/ml sol. inj./perf. i.v. flac. · Ultravist 370 370 mg/ml sol. inj./perf. i.v. flac.United Kingdom
Ultravist 150 · Ultravist 150 solution for injection 50ml vials · Ultravist 240 · Ultravist 240 solution for injection 50ml bottles · Ultravist 300 · Ultravist 300 solution for injection 100ml bottles · Ultravist 300 solution for injection 200ml bottles · Ultravist 300 solution for injection 20ml vials · Ultravist 300 solution for injection 50ml bottles · Ultravist 300 solution for injection 75ml bottles · Ultravist 370 · Ultravist 370 solution for injection 100ml bottles · Ultravist 370 solution for injection 200ml bottles · Ultravist 370 solution for injection 30ml bottles · Ultravist 370 solution for injection 50ml bottles · Ultravist 370 solution for injection 75ml bottlesDenmark
UltravistPoland
Ultravist 300 · Ultravist 370Luxembourg
ULTRAVIST · ULTRAVIST-240 · ULTRAVIST-300 · ULTRAVIST-370Latvia
UltravistSerbia
Ultravist · Ultravist® 370
© NAPOS 2024